Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases: A Step Towards Precision Medicine
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Individuals (male or female) aged 20 years or older
• Willing and able to provide written informed consent to participate in the study
Locations
Other Locations
Taiwan
Chang Gung Memorial Hospitals, Linkou
RECRUITING
Taoyuan District
Contact Information
Primary
Chi-Hsiao Yeh, MD PhD
yehccl@cgmh.org.tw
+886-3-3281200
Time Frame
Start Date: 2025-06-09
Estimated Completion Date: 2035-09-30
Participants
Target number of participants: 6266
Treatments
whole cohort
Participants who meet the diagnostic criteria for metabolic syndrome, as defined by the International Diabetes Federation (IDF) and/or ATP III guidelines and those participants without metabolic syndrome who are matched to the study group by age and sex. These individuals will undergo annual biospecimen collection (blood, urine, and stool) and longitudinal clinical follow-up to identify molecular signatures associated with disease progression and metabolic complications.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital